Tratamiento esclerosante del linfangioma facial. Presentación de un caso / Sclerotherapic treatment of facial lymphangioma
Prensa méd. argent
; 105(1): 41-46, mar 2019.
Article
em Es
| BINACIS, LILACS
| ID: biblio-1026344
Biblioteca responsável:
AR392.1
ABSTRACT
This article details the treatment of lymphangioma of the face with intralesional bleomycin with a case report and literature review. Surgical treatment of lymphangioma of the face is a difficult task to achieve, due to close vicinity of the lesion to the facial nerve and possibility of scar tissue formation. Inefficient surgical removals generally will give rise to high recurrence rates because of infiltrative and diffuse extension of the lesion. However, complete cure has been described by non-surgical methods with intralesional bleomycin injection under ultrasonographic guidance. Lymphangioma is a rare congenital malformation of the lymphatic system, frequently seen in the head and neck. Percutaneous sclerotherapy of lymphangioma involves the injection of sclerosing substances into the lymphangioma. This study aims to evaluate the effectiveness of intralesional bleomycin sclerotherapy in the treatment of lymphangioma, and to determine the incidence of complications in the treatment. Intralesional bleomycin therapy was very effective in the treatment of lymphangioma. Bleomycin administered as intralesional injection was found to be safe as there was no lesions complicating or side effects observed in the study.
Palavras-chave
Índice:
LILACS
Assunto principal:
Bleomicina
/
Escleroterapia
/
Traumatismos Faciais
/
Linfangioma
Tipo de estudo:
Guideline
/
Observational_studies
Limite:
Adolescent
/
Female
/
Humans
Idioma:
Es
Revista:
Prensa méd. argent
Assunto da revista:
MEDICINA
Ano de publicação:
2019
Tipo de documento:
Article